v3.25.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Class A Common Stock, Class B Common Stock and Class C Capital Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021     250,630          
Beginning balance at Dec. 31, 2021 $ 5,341 $ (336) $ 0 $ 7,001 $ (492) $ (1,667) $ 156 $ 7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of capital stock upon exercise of stock options (in shares)     1,129          
Issuance of Class C capital stock upon exercise of stock options 45     45        
Vesting of restricted stock units (in shares)     4,722          
Share-based compensation expense 502     502        
Repurchases of Class A common stock and Class C capital stock (in shares)     (22,213)          
Repurchases of Class A common stock and Class C capital stock (947)     (947)        
Net loss (101)         (101)    
Other comprehensive income (loss) (22)             (22)
Ending balance (in shares) at Dec. 31, 2022     234,268          
Ending balance at Dec. 31, 2022 4,482   $ 0 6,109   (1,612)   (15)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of capital stock upon exercise of stock options (in shares)     1,829          
Issuance of Class C capital stock upon exercise of stock options 72     72        
Vesting of restricted stock units (in shares)     6,400          
Share-based compensation expense 524     524        
Repurchases of Class A common stock and Class C capital stock (in shares)     (9,523)          
Repurchases of Class A common stock and Class C capital stock (424)     (424)        
Issuance of Class C capital stock in connection with an acquisition (in shares)     380          
Issuance of Class C capital stock in connection with an acquisition 20     20        
Net loss (158)         (158)    
Other comprehensive income (loss) 10             10
Ending balance (in shares) at Dec. 31, 2023     233,354          
Ending balance at Dec. 31, 2023 $ 4,526   $ 0 6,301   (1,770)   (5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of capital stock upon exercise of stock options (in shares) 5,474   5,474          
Issuance of Class C capital stock upon exercise of stock options $ 212     212        
Vesting of restricted stock units (in shares)     6,436          
Share-based compensation expense 520     520        
Settlement of capped call transactions     (2,141)          
Settlement of convertible senior notes (in shares)     6,462          
Settlement of convertible senior notes 1     1        
Repurchases of Class A common stock and Class C capital stock (in shares)     (7,096)          
Repurchases of Class A common stock and Class C capital stock (301)     (301)        
Net loss (112)         (112)    
Other comprehensive income (loss) 2             2
Ending balance (in shares) at Dec. 31, 2024     242,489          
Ending balance at Dec. 31, 2024 $ 4,848   $ 0 $ 6,733   $ (1,882)   $ (3)